  See all
 |
Articles: Pharmacology/kinetics |
Prior Articles
The Efficacy of Octreotide LAR as Firstline Therapy for Patients with Newly Diagnosed Acromegaly is Independent of Tumor Extension: Predictive Factors of Tumor and Biochemical Response
Hormone and Metabolic Research, 10/06/09
Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly
European Journal of Endocrinology, 10/06/09 Beyond Glycemic Control: Treating the Entire Type 2 Diabetes Disorder
Postgraduate Medicine, 10/05/09 Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
Diabetes Technology & Therapeutics, 10/05/09 A Comparison Between Simplified and Intensive Dose-Titration Algorithms Using AIR Inhaled Insulin for Insulin-Naive Patients with Type 2 Diabetes in a Randomized Noninferiority Trial
Diabetes Technology & Therapeutics, 10/05/09 AIR Insulin Capsules of Different Dose Strengths May Be Combined to Yield Equivalent Pharmacokinetics and Glucodynamics
Diabetes Technology & Therapeutics, 10/05/09 Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17)
Diabetic Medicine, 10/02/09 Does Availability of AIR Insulin Increase Insulin Use and Improve Glycemic Control in Patients with Type 2 Diabetes
Diabetes Technology & Therapeutics, 10/02/09 Safety and Efficacy of AIR Inhaled Insulin Compared with Subcutaneous Insulin in Patients Having Diabetes and Asthma: A 12-Month, Randomized, Noninferiority Trial
Diabetes Technology & Therapeutics, 10/02/09 Initiation of Prandial Insulin Therapy with AIR Inhaled Insulin or Insulin Lispro in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial
Diabetes Technology & Therapeutics, 10/02/09 Dose Accuracy of SoloSTAR and FlexPen as Assessed in a Clinical Setting
Diabetes Technology & Therapeutics, 10/02/09 Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
Current Medical Research and Opinion, 10/02/09 Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09 Quantitative Computed Tomography Assessment of the Effects of 24 months of Teriparatide Treatment on 3-D Femoral Neck Bone Distribution, Geometry and Bone Strength: Results from the EUROFORS Study
Journal of Bone and Mineral Research, 10/01/09 Serum 25(OH)D Levels Modulate the Acute Phase Response Associated to the First Nitrogen Containing Bisphosphonate Infusion
Journal of Bone and Mineral Research, 10/01/09 The Effect of Prior Bisphosphonate Therapy on the Subsequent BMD and Bone Turnover Response to Strontium Ranelate
Journal of Bone and Mineral Research, 10/01/09 The Effect of Prescription Omega-3 Fatty Acids on Body Weight After 8 to 16 Weeks of Treatment for Very High Triglyceride Levels
Postgraduate Medicine, 09/30/09 A Comparison of Injection Force and Dosage Scale Size Between NovoPen3 and NovoPen4
Diabetes Technology & Therapeutics, 09/30/09 Socioeconomic Differences in Preferences and Willingness-to-Pay for Insulin Delivery Systems in Type 1 and Type 2 Diabetes
Diabetes Technology & Therapeutics, 09/30/09 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
Current Medical Research and Opinion, 09/30/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes
more...
|
250 Available Pages
|
|
